Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.
Department of Medical Research, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC.
J Chin Med Assoc. 2021 Nov 1;84(11):1028-1037. doi: 10.1097/JCMA.0000000000000626.
The coronavirus disease 2019 (COVID-19) pandemic continues to affect countries worldwide. To inhibit the transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), testing of patients, contact tracing, and quarantine of their close contacts have been used as major nonpharmaceutical interventions. The advantages of antigen tests, such as low cost and rapid turnaround, may allow for the rapid identification of larger numbers of infectious persons. This meta-analysis aimed to evaluate the diagnostic accuracy of antigen tests for SARS-CoV-2.
We searched PubMed, Embase, Cochrane Library, and Biomed Central databases from inception to January 2, 2021. Studies evaluating the diagnostic accuracy of antigen testing for SARS-CoV-2 with reference standards were included. We included studies that provided sufficient data to construct a 2 × 2 table on a per-patient basis. Only articles in English were reviewed. Summary sensitivity and specificity for antigen tests were generated using a random-effects model.
Fourteen studies with 8624 participants were included. The meta-analysis for antigen testing generated a pooled sensitivity of 79% (95% CI, 66%-88%; 14 studies, 8624 patients) and a pooled specificity of 100% (95% CI, 99%-100%; 14 studies, 8624 patients). The subgroup analysis of studies that reported specimen collection within 7 days after symptom onset showed a pooled sensitivity of 95% (95% CI, 78%-99%; four studies, 1342 patients) and pooled specificity of 100% (95% CI, 97%-100%; four studies, 1342 patients). Regarding the applicability, the patient selection, index tests, and reference standards of studies in our meta-analysis matched the review title.
Antigen tests have moderate sensitivity and high specificity for the detection of SARS-CoV-2. Antigen tests might have a higher sensitivity in detecting SARS-CoV-2 within 7 days after symptom onset. Based on our findings, antigen testing might be an effective method for identifying contagious individuals to block SARS-CoV-2 transmission.
2019 年冠状病毒病(COVID-19)大流行继续影响着全球各国。为了抑制严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的传播,对患者进行检测、接触者追踪和密切接触者隔离已被用作主要的非药物干预措施。抗原检测具有成本低、周转快等优势,可能能够快速识别出更多的传染性感染者。本荟萃分析旨在评估 SARS-CoV-2 抗原检测的诊断准确性。
我们从建库至 2021 年 1 月 2 日检索了 PubMed、Embase、Cochrane 图书馆和 Biomed Central 数据库。纳入了评估参考标准下 SARS-CoV-2 抗原检测诊断准确性的研究。我们纳入了提供了足够数据以便基于每位患者构建 2×2 表格的研究。仅审查了英文文章。使用随机效应模型生成抗原检测的汇总敏感性和特异性。
纳入了 14 项涉及 8624 名参与者的研究。抗原检测的荟萃分析得出的汇总敏感性为 79%(95%CI,66%-88%;14 项研究,8624 名患者),汇总特异性为 100%(95%CI,99%-100%;14 项研究,8624 名患者)。对报告症状出现后 7 天内采集标本的研究进行亚组分析,得出的汇总敏感性为 95%(95%CI,78%-99%;四项研究,1342 名患者)和汇总特异性为 100%(95%CI,97%-100%;四项研究,1342 名患者)。关于适用性,我们荟萃分析中的研究患者选择、指标检测和参考标准与综述标题相匹配。
抗原检测对 SARS-CoV-2 的检测具有中等敏感性和高度特异性。抗原检测在症状出现后 7 天内检测 SARS-CoV-2 可能具有更高的敏感性。根据我们的发现,抗原检测可能是一种有效识别传染性个体以阻断 SARS-CoV-2 传播的方法。